These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6641028)

  • 1. Oral aluminum toxicity in a non-dialyzed patient with renal failure.
    Kaye M
    Clin Nephrol; 1983 Oct; 20(4):208-11. PubMed ID: 6641028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum and renal osteodystrophy in chronic uremia.
    Berland Y; Grandvuillemin M; Charhon S; Olmer M
    Kidney Int Suppl; 1985 Dec; 17():S183-7. PubMed ID: 3867793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism.
    Papadakis JT; Patrikarea A; Digenis GE; Stamatelou K; Ntaountaki I; Athanasopoulos V; Tamvakis N
    Nephron; 1996; 72(2):308-12. PubMed ID: 8684546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].
    Gordillo-Paniagua G; Valencia-Mayoral P; Mercado L; Medina-Mercado M
    Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic renal failure and radiological appearance of hyperparathyroidism (2). Soft-part calcifications (author's transl)].
    Watanabe T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(8):733-41. PubMed ID: 7339586
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aluminum in chronic renal failure].
    Głuszek J; Adamczak H
    Rocz Panstw Zakl Hig; 1993; 44(1):43-8. PubMed ID: 8235341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical images: Aluminum-modified renal osteopathy.
    Buttgereit F; Loreck D; Burmester GR; Abendroth K
    Arthritis Rheum; 1997 Sep; 40(9):1724. PubMed ID: 9324031
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidism.
    Vosik WM; Anderson CF; Steffee WP; Johnson WJ; Arnaud CD; Goldsmith RS
    Mayo Clin Proc; 1972 Feb; 47(2):110-3. PubMed ID: 5010725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measurement of aluminium in bone by pulse polarography (author's transl)].
    Burnel D; Hutin MF; Netter P; Kessler M; Huriet C; Gaucher A
    Pathol Biol (Paris); 1982 Jan; 30(1):27-32. PubMed ID: 7038598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW; Stewart Wk; Fell GS; Halls DJ
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperparathyroidism and bone aluminum deposits may coexist.
    Olmer M; Berland Y; Toga M; Charhon S
    Contrib Nephrol; 1985; 49():38-44. PubMed ID: 3830569
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic renal failure and radiological appearance of hyperparathyroidism.(1) Bone changes (author's transl)].
    Watanabe T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jun; 41(6):497-504. PubMed ID: 7322850
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.
    Yamaguchi T; Sugimoto T; Imai Y; Fukase M; Fujita T; Chihara K
    Bone; 1995 Apr; 16(4 Suppl):247S-250S. PubMed ID: 7626311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extra-osseous calcification and its regression after treatment in a case of long-term hemodialysis].
    Kuhlencordt F; Augustin HJ; Kruse HP
    Dtsch Med Wochenschr; 1970 Oct; 95(42):2122-5. PubMed ID: 4990903
    [No Abstract]   [Full Text] [Related]  

  • 19. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A; Sulková S; Laurinová Z
    Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.